Background: Inclusion of anticancer drugs into biocompatible nanoparticulate carriers decreases the general toxicity and
improves the efficacy of clinical treatments due to the reduction of soluble circulating free drug.
Methods: In addition, removal of emerging drug contaminants from wastewaters is a necessity that should be seriously
attended. Boron nitride (BN) is choice in drug delivery because of many surprising properties. Here, boron nitride
nanoparticles are prepared, characterized by Fourier-transform infrared spectroscopy (FT-IR) and x-ray diffraction (XRD)
and used in the delivery of melphalan anti-cancer drug.
Results: Then, density functional theory (DFT) calculations are carried out to study adsorption of this drug on the surface of
pure boron nitride fullerene via familiar hybrid functionals B3LYP and B3PW91. In addition, the polarizable continuum
model (PCM) calculations show that BN is stable in water.
Conclusion: Finally, the in vitro cellular toxicity and viability of BN nanoparticles was examined on ES-2 cancer cells. The
inhibitory dose IC50 of the material confirmed an acceptable cytotoxicity and nanoparticles affected the average growth of
ES-2 cancer cells.